Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.
2.

[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].

Pozio E.

Parassitologia. 2004 Jun;46(1-2):89-93. Review. Italian.

PMID:
15305694
3.

[Prevention of opportunistic infections in the protease inhibitor era].

Viciana P, Miralles-Martín P, Knobel H, Gatell JM.

Enferm Infecc Microbiol Clin. 1998;16 Suppl 1:1-10. Review. Spanish.

PMID:
9859614
4.

HIV infection and AIDS.

Lloyd A.

P N G Med J. 1996 Sep;39(3):174-80. Review.

PMID:
9795558
5.

[AIDS associated cancers in the era of highly active antiretroviral therapy (HAART)].

Tserenpuntsag B, Kołacińska A, Jabłonowska E.

Przegl Epidemiol. 2007;61(3):529-34. Review. Polish.

PMID:
18069390
6.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
7.
8.

Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.

Torre D, Speranza F, Martegani R.

HIV Med. 2005 Mar;6(2):66-78. Review.

9.

The epidemiology of acquired immunodeficiency syndrome malignancies.

Goedert JJ.

Semin Oncol. 2000 Aug;27(4):390-401. Review.

PMID:
10950365
10.

Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review.

Cobucci RN, Lima PH, de Souza PC, Costa VV, Cornetta Mda C, Fernandes JV, Gonçalves AK.

J Infect Public Health. 2015 Jan-Feb;8(1):1-10. doi: 10.1016/j.jiph.2014.08.003. Epub 2014 Oct 5. Review.

PMID:
25294086
11.

AIDS malignancies in the era of highly active antiretroviral therapy.

Gates AE, Kaplan LD.

Oncology (Williston Park). 2002 Apr;16(4):441-51, 456, 459. Review.

12.

Impact of HAART on the clinical management of AIDS-related cancers.

Tirelli U, Bernardi D.

Eur J Cancer. 2001 Jul;37(10):1320-4. Review.

PMID:
11423264
13.

Update on HIV/AIDS in Thailand.

Ruxrungtham K, Phanuphak P.

J Med Assoc Thai. 2001 Jun;84 Suppl 1:S1-17. Review.

PMID:
11529320
14.

AIDS-related cancers in the era of highly active antiretroviral therapy.

Biggar RJ.

Oncology (Williston Park). 2001 Apr;15(4):439-48; discussion 448-9. Review.

15.

Human immunodeficiency virus infection, Part II.

Horowitz HW, Telzak EE, Sepkowitz KA, Wormser GP.

Dis Mon. 1998 Dec;44(12):677-716. Review.

PMID:
9883269
16.

Pneumocystis carinii pneumonia.

Schliep TC, Yarrish RL.

Semin Respir Infect. 1999 Dec;14(4):333-43. Review.

PMID:
10638513
17.
18.

Trends in overall opportunistic illnesses, Pneumocystis carinii pneumonia, cerebral toxoplasmosis and Mycobacterium avium complex incidence rates over the 30 years of the HIV epidemic: a systematic review.

Coelho L, Veloso VG, Grinsztejn B, Luz PM.

Braz J Infect Dis. 2014 Mar-Apr;18(2):196-210. doi: 10.1016/j.bjid.2013.10.003. Epub 2013 Nov 23. Review.

19.

[Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].

Pulido F, Iribarren JA, Kindelan JM, Moreno S.

Enferm Infecc Microbiol Clin. 1998;16 Suppl 1:20-8. Review. Spanish.

PMID:
9859616
20.

Epidemiology of AIDS-related tumours in developed and developing countries.

Dal Maso L, Serraino D, Franceschi S.

Eur J Cancer. 2001 Jul;37(10):1188-201. Review.

PMID:
11423251
Items per page

Supplemental Content

Write to the Help Desk